Half-year report · Q2
4937.TEDINET S100VR3K
Period2024-10-01 → 2025-03-31
Filed2025-05-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥835m | 2024-10-01 → 2025-03-31 | Cons. | Net sales |
| Revenue | ¥1.9bn | 2023-10-01 → 2024-09-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥934m | 2023-10-01 → 2024-03-31 | Cons. | Net sales |
| Operating income | −¥52m | 2024-10-01 → 2025-03-31 | Cons. | Operating income |
| Operating income | −¥87m | 2023-10-01 → 2024-03-31 | Cons. | Operating income |
| Ordinary income | −¥55m | 2024-10-01 → 2025-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥57m | 2023-10-01 → 2024-09-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥84m | 2023-10-01 → 2024-03-31 | Cons. | Ordinary income |
| Profit before tax | −¥55m | 2024-10-01 → 2025-03-31 | Cons. | Income before income taxes |
| Profit before tax | −¥84m | 2023-10-01 → 2024-03-31 | Cons. | Income before income taxes |
| Net income (owners) | −¥59m | 2024-10-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥17m | 2023-10-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥111m | 2023-10-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥59m | 2024-10-01 → 2025-03-31 | Cons. | Profit loss |
| Net income | −¥111m | 2023-10-01 → 2024-03-31 | Cons. | Profit loss |
| Total assets | ¥3.0bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥3.1bn | at 2024-09-30 | Cons. | Assets |
| Total assets | ¥3.1bn | at 2024-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥964m | at 2025-03-31 | Cons. | Liabilities |
| Total liabilities | ¥993m | at 2024-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥2.1bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥2.1bn | at 2024-09-30 | Cons. | Net assets |
| Net assets / equity | ¥2.0bn | at 2024-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.3bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.5bn | at 2024-09-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.3bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.5bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.5bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.3bn | at 2023-09-30d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥10m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥49m | 2023-10-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥67m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥88m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥76m | 2023-10-01 → 2024-09-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥12m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥123m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥112m | 2023-10-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥130m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-16.36 | 2024-10-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-5.03 | 2023-10-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-33.54 | 2023-10-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 67.9% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 68.2% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 66.2% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 24
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2024-10-01 → 2025-03-31 | −¥187m |
| jpcrp040300-q2r_E36697-000Direct To Consumer Businessreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥503m |
| jpcrp040300-q2r_E36697-000Direct To Consumer Businessreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥503m |
| jpcrp040300-q2r_E36697-000Direct To Consumer Businessreportable segment | segment profit | 2024-10-01 → 2025-03-31 | ¥144m |
| jpcrp040300-q2r_E36697-000Medical Supportreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥332m |
| jpcrp040300-q2r_E36697-000Medical Supportreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥332m |
| jpcrp040300-q2r_E36697-000Medical Supportreportable segment | segment profit | 2024-10-01 → 2025-03-31 | −¥9m |
| —segment total | revenue | 2024-10-01 → 2025-03-31 | ¥835m |
| —segment total | revenue external | 2024-10-01 → 2025-03-31 | ¥835m |
| —segment total | segment profit | 2024-10-01 → 2025-03-31 | ¥135m |
| Reconciling Itemsreconciling | revenue | 2023-10-01 → 2024-03-31 | −¥75,000 |
| Reconciling Itemsreconciling | revenue intersegment | 2023-10-01 → 2024-03-31 | −¥75,000 |
| Reconciling Itemsreconciling | segment profit | 2023-10-01 → 2024-03-31 | −¥200m |
| jpcrp040300-q2r_E36697-000Direct To Consumer Businessreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥712m |
| jpcrp040300-q2r_E36697-000Direct To Consumer Businessreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥712m |
| jpcrp040300-q2r_E36697-000Direct To Consumer Businessreportable segment | revenue intersegment | 2023-10-01 → 2024-03-31 | ¥75,000 |
| jpcrp040300-q2r_E36697-000Direct To Consumer Businessreportable segment | segment profit | 2023-10-01 → 2024-03-31 | ¥154m |
| jpcrp040300-q2r_E36697-000Medical Supportreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥222m |
| jpcrp040300-q2r_E36697-000Medical Supportreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥222m |
| jpcrp040300-q2r_E36697-000Medical Supportreportable segment | segment profit | 2023-10-01 → 2024-03-31 | −¥42m |
| —segment total | revenue | 2023-10-01 → 2024-03-31 | ¥934m |
| —segment total | revenue external | 2023-10-01 → 2024-03-31 | ¥934m |
| —segment total | revenue intersegment | 2023-10-01 → 2024-03-31 | ¥75,000 |
| —segment total | segment profit | 2023-10-01 → 2024-03-31 | ¥113m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 432
| Item | Context | Value | Unit |
|---|---|---|---|
| Depreciation and amortization ope cf | Prior1YTDDuration | 3843000 | JPY |
| Depreciation and amortization ope cf | CurrentYTDDuration | 6463000 | JPY |
| Amortization of goodwill ope cf | Prior1YTDDuration | 30595000 | JPY |
| Amortization of goodwill ope cf | CurrentYTDDuration | 61191000 | JPY |
| Share based compensation expenses ope cf | Prior1YTDDuration | 2279000 | JPY |
| Share based compensation expenses ope cf | CurrentYTDDuration | 2728000 | JPY |
| Reversal of allowance for doubtful accounts ope cf | Prior1YTDDuration | -3977000 | JPY |
| Reversal of allowance for doubtful accounts ope cf | CurrentYTDDuration | － | JPY |
| Interest and dividends income ope cf | Prior1YTDDuration | -238000 | JPY |
| Interest and dividends income ope cf | CurrentYTDDuration | -460000 | JPY |
| Recoveries of written off receivables ope cf | Prior1YTDDuration | -600000 | JPY |
| Recoveries of written off receivables ope cf | CurrentYTDDuration | -1200000 | JPY |
| Interest expenses ope cf | Prior1YTDDuration | 2106000 | JPY |
| Interest expenses ope cf | CurrentYTDDuration | 3949000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | Prior1YTDDuration | 22531000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | CurrentYTDDuration | 35658000 | JPY |
| Decrease increase in inventories ope cf | Prior1YTDDuration | -1354000 | JPY |
| Decrease increase in inventories ope cf | CurrentYTDDuration | -30377000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | Prior1YTDDuration | -6471000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | CurrentYTDDuration | -526000 | JPY |
| Decrease increase in prepaid expenses ope cf | Prior1YTDDuration | -2231000 | JPY |
| Decrease increase in prepaid expenses ope cf | CurrentYTDDuration | -3090000 | JPY |
| Decrease increase in accounts receivable other ope cf | Prior1YTDDuration | 15529000 | JPY |
| Decrease increase in accounts receivable other ope cf | CurrentYTDDuration | 500000 | JPY |
| Increase decrease in accounts payable other ope cf | Prior1YTDDuration | -22489000 | JPY |
| Increase decrease in accounts payable other ope cf | CurrentYTDDuration | 27673000 | JPY |
| Increase decrease in deposits received ope cf | Prior1YTDDuration | -8897000 | JPY |
| Increase decrease in deposits received ope cf | CurrentYTDDuration | 1993000 | JPY |
| Increase decrease in accrued expenses ope cf | Prior1YTDDuration | 4823000 | JPY |
| Increase decrease in accrued expenses ope cf | CurrentYTDDuration | 1859000 | JPY |
| Increase decrease in income taxes payable ope cf | Prior1YTDDuration | -5817000 | JPY |
| Increase decrease in income taxes payable ope cf | CurrentYTDDuration | － | JPY |
| Increase decrease in accrued or accrued consumption taxes ope cf | Prior1YTDDuration | -2621000 | JPY |
| Increase decrease in accrued or accrued consumption taxes ope cf | CurrentYTDDuration | 17959000 | JPY |
| Decrease increase in other current assets ope cf | Prior1YTDDuration | － | JPY |
| Decrease increase in other current assets ope cf | CurrentYTDDuration | -10351000 | JPY |
| Other net ope cf | Prior1YTDDuration | -31517000 | JPY |
| Other net ope cf | CurrentYTDDuration | 3932000 | JPY |
| Subtotal ope cf | Prior1YTDDuration | -88807000 | JPY |
| Subtotal ope cf | CurrentYTDDuration | 63336000 | JPY |
| Interest and dividends income received ope cf inv cf | Prior1YTDDuration | 5000 | JPY |
| Interest and dividends income received ope cf inv cf | CurrentYTDDuration | 389000 | JPY |
| Interest expenses paid ope cf fin cf | Prior1YTDDuration | -2053000 | JPY |
| Interest expenses paid ope cf fin cf | CurrentYTDDuration | -3949000 | JPY |
| Income taxes paid refund ope cf | Prior1YTDDuration | 23364000 | JPY |
| Income taxes paid refund ope cf | CurrentYTDDuration | -49823000 | JPY |
| Net cash provided by used in operating activities | Prior1YTDDuration | -67490000 | JPY |
| Net cash provided by used in operating activities | CurrentYTDDuration | 9953000 | JPY |
| Proceeds from written of receivables inv cf | Prior1YTDDuration | 600000 | JPY |
| Proceeds from written of receivables inv cf | CurrentYTDDuration | 1200000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |